XML 90 R75.htm IDEA: XBRL DOCUMENT v3.25.3
SHARE-BASED COMPENSATION - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share-Based payment, expense $ 7 $ 5 $ 20 $ 18
Fair value of vested RSUs and PSUs     $ 24  
Performance Shares (PSUs)        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Granted weighted average grant date fair value during the period (in USD per share)     $ 17.88  
Share-based compensation, unrecognized compensation expense 29   $ 29  
Remaining weighted average vesting period     2 years  
Performance Shares (PSUs) | Share-Based payment arrangement, employee        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share granted during the period (in shares)     1,154,859  
Share-based compensation, vesting period     3 years  
Performance Shares (PSUs) | Minimum | Share-Based payment arrangement, employee        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Percentage of share-based payments vesting multiplier     0.00%  
Performance Shares (PSUs) | Maximum | Share-Based payment arrangement, employee        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Percentage of share-based payments vesting multiplier     200.00%  
Restricted Stock Units (RSUs)        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share-based compensation, unrecognized compensation expense $ 18   $ 18  
Remaining weighted average vesting period     2 years  
Restricted Stock Units (RSUs) | Share-Based payment arrangement, employee        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share granted during the period (in shares)     1,026,520  
Share-based compensation, vesting period     3 years  
Granted weighted average grant date fair value during the period (in USD per share)     $ 11.90